Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-17

Clinical Trial Update: Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates the efficacy, safety and cost-effectiveness of a sequential topical therapy (RV4104A ointment, ciclopiroxolamine cream, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amorolfine Nail Lacquer (amorolfine)
  • Ciclopirox Film-forming Solution (ciclopirox)
  • Ciclopiroxolamine Cream (ciclopiroxolamine)
  • RV4104A Ointment (RV4104A)

Snippet

Sponsor: Pierre Fabre Dermo Cosmetique | Conditions: Onychomycosis | Phase 4 | Status: UNKNOWN